A Randomized Controlled Trial to Assess the Long-Term Health Effects of Smoking Cessation Intervention through a Tobacco Harm Reduction Product among Type 2 Diabetic Smokers in Bangladesh- Study Protocol of the DISC Trial
validated by expired-air carbon monoxide at week-12, and clinical outcomes (pulmonary, liver, and kidney functions; inflammatory biomarker, body composition, blood glucose and HbAc1, blood pressure, and lipid profile

